By SIMON CONSTABLE
Amgen posted first-quarter earnings that fell from a year earlier but the results beat analysts' expectations.
The biotech company reported earnings per share of $3.18 for the first three months of the year vs. $3.25 for the same period in 2018. Adjusted earnings in the quarter were $3.56 a share, above forecasts of $3.48. Read more here.
Amgen posted first-quarter earnings that fell from a year earlier but the results beat analysts' expectations.
The biotech company reported earnings per share of $3.18 for the first three months of the year vs. $3.25 for the same period in 2018. Adjusted earnings in the quarter were $3.56 a share, above forecasts of $3.48. Read more here.
No comments:
Post a Comment